drugset
drugset / Trial / NCT02825186

Dexamethasone (Sterodex) Versus Loteprendol (Lotemax) Eye Drops Following Strabismus Surgery

NCT02825186 ↗

Unknown 100 enrolled Tel-Aviv Sourasky Medical Center
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to compare the efficacy and side effects of topical Loteprendol etabonate 0.5% (Lotemax) versus Dexamethasone 0.1% (Sterodex) following strabismus surgery.

Timeline

Start
2016-07
Primary completion
2018-06
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.1 % Topical
Subject Loteprendol etabonate Unknown 0.5 % Topical

Indications

No indication recorded.